Authors
Jayson, Gordon CAffiliation
Christie Hospital and University of Manchester, Academic Health Sciences Centre, Manchester, UK.Issue Date
2011-11
Metadata
Show full item recordCitation
VEGF inhibitors and advanced ovarian cancer. 2011, 12 (12):1082-3 Lancet OncolJournal
Lancet OncologyDOI
10.1016/S1470-2045(11)70269-8PubMed ID
21992854Type
ArticleLanguage
enISSN
1474-5488ae974a485f413a2113503eed53cd6c53
10.1016/S1470-2045(11)70269-8
Scopus Count
Related articles
- Controversy in treatment of advanced ovarian cancer.
- Authors: Scambia G, Salutari V, Amadio G
- Issue date: 2013 Sep
- Comment on "Primary chemotherapy for inoperable ovarian, fallopian tube, or primary peritoneal cancer with or without delayed debulking surgery".
- Authors: Barton DP, Naik R, Pomel C
- Issue date: 2012 Sep
- Bevacizumab in ovarian cancer: unanswered questions.
- Authors: Muggia F
- Issue date: 2012 May 7
- Nintedanib and ovarian cancer: standardise surgery in trials?
- Authors: Kehoe S
- Issue date: 2016 Jan
- Transparency in interim monitoring.
- Authors: Freidlin B, Korn EL
- Issue date: 2014 Aug 1